|
1
|
Mak VC, Siu MK, Wong OG, Chan KK, Ngan HY
and Cheung AN: Dysregulated stemness-related genes in gynecological
malignancies. Histol Histopathol. 27:1121–1130. 2012.PubMed/NCBI
|
|
2
|
Kemmerling R, Alinger B, Dietze O,
Bösmüller HC, Ocker M, Wolkersdörfer GW, Berr F, Neureiter D and
Kiesslich T: Association of stem cell marker expression pattern and
survival in human biliary tract cancer. Int J Oncol. 41:511–522.
2012.PubMed/NCBI
|
|
3
|
Chiu CG, Chan SK, Fang ZA, Masoudi H,
Wood-Baker R, Jones SJ, Gilks B, Laskin J and Wiseman SM:
Beta-catenin expression is prognostic of improved non-small cell
lung cancer survival. Am J Surg. 203:654–659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu C, Xie D, Yu SC, Yang XJ, He LR, Yang
J, Ping YF, Wang B, Yang L, Xu SL, et al: β-Catenin/POU5F1/SOX2
transcription factor complex mediates IGF-I receptor signaling and
predicts poor prognosis in lung adenocarcinoma. Cancer Res.
73:3181–3189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nayerossadat N, Maedeh T and Ali PA: Viral
and nonviral delivery systems for gene delivery. Adv Biomed Res.
1:272012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levina V, Marrangoni A, Wang T, Parikh S,
Su Y, Herberman R, Lokshin A and Gorelik E: Elimination of human
lung cancer stem cells through targeting of the stem cell
factor-c-kit autocrine signaling loop. Cancer Res. 70:338–346.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meng X, Wang X and Wang Y: More than 45%
of A549 and H446 cells are cancer initiating cells: evidence from
cloning and tumorigenic analyses. Oncol Rep. 21:995–1000.
2009.PubMed/NCBI
|
|
8
|
Huang D, Gao Q, Guo L, Zhang C, Jiang W,
Li H, Wang J, Han X, Shi Y and Lu SH: Isolation and identification
of cancer stem-like cells in esophageal carcinoma cell lines. Stem
Cells Dev. 18:465–473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guzman ML, Swiderski CF, Howard DS, Grimes
BA, Rossi RM, Szilvassy SJ and Jordan CT: Preferential induction of
apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci
USA. 99:16220–16225. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Houghton J, Stoicov C, Nomura S, Rogers
AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC:
Gastric cancer originating from bone marrow-derived cells. Science.
306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abbott BL: ABCG2 (BCRP): a cytoprotectant
in normal and malignant stem cells. Clin Adv Hematol Oncol.
4:63–72. 2006.PubMed/NCBI
|
|
12
|
Vermeulen L, De Sousa E, Melo F, van der
Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M,
Merz C, Rodermond H, et al: Wnt activity defines colon cancer stem
cells and is regulated by the microenvironment. Nat Cell Biol.
12:468–476. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen D, Zhao M and Mundy GR: Bone
morphogenetic proteins. Growth Factors. 22:233–241. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim YS, Farrar W, Colburn NH and Milner
JA: Cancer stem cells: potential target for bioactive food
components. J Nutr Biochem. 23:691–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu S, Dontu G, Mantle ID, Patel S, Ahn
NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1
regulate self-renewal of normal and malignant human mammary stem
cells. Cancer Res. 66:6063–6071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lessard J and Sauvageau G: Bmi-1
determines the proliferative capacity of normal and leukaemic stem
cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stovall DB, Wan M, Zhang Q, Dubey P and
Sui G: DNA vector-based RNA interference to study gene function in
cancer. J Vis Exp. 64:e41292012.PubMed/NCBI
|
|
18
|
Tsai LL, Yu CC, Chang YC, Yu CH and Chou
MY: Markedly increased Oct4 and Nanog expression correlates with
cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol
Med. 40:621–628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu TT, Liu SY and Zheng PS: Cytoplasmic
NANOG-positive stromal cells promote human cervical cancer
progression. Am J Pathol. 181:652–661. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nagata T, Shimada Y, Sekine S, Hori R,
Matsui K, Okumura T, Sawada S, Fukuoka J and Tsukada K: Prognostic
significance of NANOG and KLF4 for breast cancer. Breast Cancer.
21:96–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu X, Mazur SJ, Lin T, Appella E and Xu Y:
The pluripotency factor nanog promotes breast cancer tumorigenesis
and metastasis. Oncogene. 33:2655–2664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Primo MN, Bak RO and Mikkelsen JG:
Lentiviral vectors for cutaneous RNA managing. Exp Dermatol.
21:162–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cavazza A, Moiani A and Mavilio F:
Mechanisms of retroviral integration and mutagenesis. Hum Gene
Ther. 24:119–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rodriguez GP, Song JB and Crouse GF:
Transformation with oligonucleotides creating clustered changes in
the yeast genome. PLoS One. 7:e429052012. View Article : Google Scholar : PubMed/NCBI
|
